Addition of a water-soluble propofol formulation to preservation solution in experimental kidney transplantation

Transplantation

Volumn 92, Issue 3, 2011, Pages 296-302

  Snoeijs, Maarten G J ^a   Vaahtera, Lauri ^b   De Vries, Eva E ^a   Schurink, Geert Willem H ^a   Haenen, Guido R M M ^a   Peutz Kootstra, Carine J ^a   Buurman, Wim A ^a   Van Heurn, L W Ernest ^a   Parkkinen, Jaakko ^b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Antioxidants; Kidney transplantation; Organ preservation

Indexed keywords

BUTYLCRESOL; CYCLODEXTRIN; DIPROPOFOL; LACTATE DEHYDROGENASE; LIPID; PHENOL DERIVATIVE; PRESERVATION SOLUTION; PROPOFOL; SYRINGOL; UNCLASSIFIED DRUG; WATER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; CRYOPRESERVATION; DRUG FORMULATION; DRUG SOLUBILITY; EXPERIMENTAL TRANSPLANTATION; HISTOPATHOLOGY; HYPOTHERMIA; IN VITRO STUDY; IN VIVO STUDY; KIDNEY AUTOTRANSPLANTATION; KIDNEY BIOPSY; KIDNEY FUNCTION; KIDNEY GRAFT; KIDNEY INJURY; KIDNEY ISCHEMIA; KIDNEY PERFUSION; KIDNEY PRESERVATION; KIDNEY TUBULE CELL; KIDNEY VASCULAR RESISTANCE; LIPID PEROXIDATION; MALE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OXIDATIVE STRESS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RENAL PROTECTION; REPERFUSION INJURY; SWINE;

ALKANES; ANESTHETICS, INTRAVENOUS; ANIMALS; ANTIOXIDANTS; CELLS, CULTURED; CHEMISTRY, PHARMACEUTICAL; CYCLODEXTRINS; DRUG CARRIERS; HYPOTHERMIA; KIDNEY TRANSPLANTATION; KIDNEY TUBULES, PROXIMAL; MALE; ORGAN PRESERVATION SOLUTIONS; OXIDATIVE STRESS; PHENOLS; PROPOFOL; REPERFUSION INJURY; SOLUBILITY; SUS SCROFA; TRANSPLANTATION, AUTOLOGOUS; WATER;

EID: 79961020837     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3182247b78     Document Type: Article

References (46)

1. Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999; 341: 1725.
2. Daemen JW, Oomen AP, Kelders WP, et al. The potential pool of nonheart-beating kidney donors. Clin Transplant 1997; 11: 149.
3. Perico N, Cattaneo D, Sayegh MH, et al. Delayed graft function in kidney transplantation. Lancet 2004; 364: 1814.
4. Halliwell B. Free radicals, antioxidants, and human disease: Curiosity, cause, or consequence? Lancet 1994; 344: 721.
5. Salahudeen AK. Cold ischemic injury of transplanted kidneys: New insights from experimental studies. Am J Physiol Renal Physiol 2004; 287: F181.
6. de Vries B, Snoeijs MG, von Bonsdorff L, et al. Redox-active iron released during machine perfusion predicts viability of ischemically injured deceased donor kidneys. Am J Transplant 2006; 6: 2686.
7. Niki E. Lipid peroxidation: Physiological levels and dual biological effects. Free Radic Biol Med 2009; 47: 469.
8. Atkinson J, Epand RF, Epand RM. Tocopherols and tocotrienols in membranes: A critical review. Free Radic Biol Med 2008; 44: 739.
9. Marik PE. Propofol: Therapeutic indications and side-effects. Curr Pharm Des 2004; 10: 3639.
10. Tsuchiya M, Asada A, Kasahara E, et al. Antioxidant protection of propofol and its recycling in erythrocyte membranes. Am J Respir Crit Care Med 2002; 165: 54.
11. Aarts L, van der Hee R, Dekker I, et al. The widely used anesthetic agent propofol can replace alpha-tocopherol as an antioxidant. FEBS Lett 1995; 357: 83.
12. Trapani A, Laquintana V, Lopedota A, et al. Evaluation of new propofol aqueous solutions for intravenous anesthesia. Int J Pharm 2004; 278: 91.
13. Friaa O, Chaleix V, Lecouvey M, et al. Reaction between the anesthetic agent propofol and the free radical DPPH in semiaqueous media: Kinetics and characterization of the products. Free Radic Biol Med 2008; 45: 1011.
14. Ogata M, Shin-Ya K, Urano S, et al. Antioxidant activity of propofol and related monomeric and dimeric compounds. Chem Pharm Bull (Tokyo) 2005; 53: 344.
15. Weaver BM, Staddon GE, Mapleson WW. Tissue/blood and tissue/water partition coefficients for propofol in sheep. Br J Anaesth 2001; 86: 693.
16. Bao YP, Williamson G, Tew D, et al. Antioxidant effects of propofol in human hepatic microsomes: Concentration effects and clinical relevance. Br J Anaesth 1998; 81: 584.
17. Javadov SA, Lim KH, Kerr PM, et al. Protection of hearts from reperfusion injury by propofol is associated with inhibition of the mitochondrial permeability transition. Cardiovasc Res 2000; 45: 360.
18. Lee CJ, Subeq YM, Lee RP, et al. Low-dose propofol ameliorates haemorrhagic shock-induced organ damage in conscious rats. Clin Exp Pharmacol Physiol 2008; 35: 766.
19. Votta-Velis EG, Minshall RD, Visintine DJ, et al. Propofol attenuates endotoxin-induced endothelial cell injury, angiotensin-converting enzyme shedding, and lung edema. Anesth Analg 2007; 105: 1363.
20. Kaplan N, Yagmurdur H, Kilinc K, et al. The protective effects of intravenous anesthetics and verapamil in gut ischemia/reperfusion-induced liver injury. Anesth Analg 2007; 105: 1371.
21. Yagmurdur H, Ayyildiz A, Karaguzel E, et al. The preventive effects of thiopental and propofol on testicular ischemia-reperfusion injury. Acta Anaesthesiol Scand 2006; 50: 1238.
22. Tyner TR, Shahbazian R, Nakashima J, et al. Propofol improves skin flap survival in a rat model: Correlating reduction in flap-induced neutrophil activity. Ann Plast Surg 2004; 53: 273.
23. Chen HI, Hsieh NK, Kao SJ, et al. Protective effects of propofol on acute lung injury induced by oleic acid in conscious rats. Crit Care Med 2008; 36: 1214.
24. Wang HH, Zhou HY, Chen CC, et al. Propofol attenuation of renal ischemia/reperfusion injury involves heme oxygenase-1. Acta Pharmacol Sin 2007; 28: 1175.
25. Yuzer H, Yuzbasioglu MF, Ciralik H, et al. Effects of intravenous anesthetics on renal ischemia/reperfusion injury. Ren Fail 2009; 31: 290.
26. Assad AR, Delou JM, Fonseca LM, et al. The role of KATP channels on propofol preconditioning in a cellular model of renal ischemiareperfusion. Anesth Analg 2009; 109: 1486.
27. Yuzbasioglu MF, Aykas A, Kurutas EB, et al. Protective effects of propofol against ischemia/reperfusion injury in rat kidneys. Ren Fail 2010; 32: 578.
28. Sanchez-Conde P, Rodriguez-Lopez JM, Nicolas JL, et al. The comparative abilities of propofol and sevoflurane to modulate inflammation and oxidative stress in the kidney after aortic cross-clamping. Anesth Analg 2008; 106: 371.
29. Basu S, Meisert I, Eggensperger E, et al. Time course and attenuation of ischaemia-reperfusion induced oxidative injury by propofol in human renal transplantation. Redox Rep 2007; 12: 195.
30. Paller MS, Hoidal JR, Ferris TF. Oxygen free radicals in ischemic acute renal failure in the rat. J Clin Invest 1984; 74: 1156.
31. Paller MS, Hedlund BE. Role of iron in postischemic renal injury in the rat. Kidney Int 1988; 34: 474.
32. Koyama I, Bulkley GB, Williams GM, et al. The role of oxygen free radicals in mediating the reperfusion injury of cold-preserved ischemic kidneys. Transplantation 1985; 40: 590.
33. Baron P, Gomez-Marin O, Casas C, et al. Renal preservation after warm ischemia using oxygen free radical scavengers to prevent reperfusion injury. J Surg Res 1991; 51: 60.
34. Toledo-Pereyra LH, Simmons RL, Olson LC, et al. Clinical effect of allopurinol on preserved kidneys: A randomized double-blind study. Ann Surg 1977; 185: 128.
35. Rabl H, Khoschsorur G, Colombo T, et al. A multivitamin infusion prevents lipid peroxidation and improves transplantation performance. Kidney Int 1993; 43: 912.
36. Pollak R, Andrisevic JH, Maddux MS, et al.Arandomized double-blind trial of the use of human recombinant superoxide dismutase in renal transplantation. Transplantation 1993; 55: 57.
37. Land W, Schneeberger H, Schleibner S, et al. The beneficial effect of human recombinant superoxide dismutase on acute and chronic rejection events in recipients of cadaveric renal transplants. Transplantation 1994; 57: 211.
38. Hower R, Minor T, Schneeberger H, et al. Assessment of oxygen radicals during kidney transplantation-effect of radical scavenger. Transpl Int 1996; 9(suppl 1): S479.
39. Norio K, Wikstrom M, Salmela K, et al. Ascorbic acid against reperfusion injury in human renal transplantation. Transpl Int 2003; 16: 480.
40. Shoskes D, Lapierre C, Cruz-Corerra M, et al. Beneficial effects of the bioflavonoids curcumin and quercetin on early function in cadaveric renal transplantation: A randomized placebo controlled trial. Transplantation 2005; 80: 1556.
41. Mathy-Hartert M, Mouithys-Mickalad A, Kohnen S, et al. Effects of propofol on endothelial cells subjected to a peroxynitrite donor (SIN-1). Anaesthesia 2000; 55: 1066.
42. Wang B, Luo T, Chen D, et al. Propofol reduces apoptosis and upregulates endothelial nitric oxide synthase protein expression in hydrogen peroxide-stimulated human umbilical vein endothelial cells. Anesth Analg 2007; 105: 1027.
43. Sachs DH. The pig as a potential xenograft donor. Vet Immunol Immunopathol 1994; 43: 185.
44. Godin DV, Garnett ME. Species-related variations in tissue antioxidant status-II. Differences in susceptibility to oxidative challenge. Comp Biochem Physiol B 1992; 103: 743.
45. Pilz J, Meineke I, Gleiter CH. Measurement of free and bound malondialdehyde in plasma by high-performance liquid chromatography as the 2,4-dinitrophenylhydrazine derivative. J Chromatogr B Biomed Sci Appl 2000; 742: 315.
46. Leemans JC, Stokman G, Claessen N, et al. Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney. J Clin Invest 2005; 115: 2894.